Castleview Partners, LLC
- SEC CIK
- 0001737088
- Latest filing
- Jul 20, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Castleview Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −233−100.0% | Sold out | Holders |
| Q4 2023 | 233 | $17.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 233 | $16.1K | <0.1% | −64−21.5% | Reduced | Holders |
| Q2 2023 | 297 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 297 | $24.6K | <0.1% | +297 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −487−100.0% | Sold out | Holders |
| Q3 2022 | 487 | $40.0K | <0.1% | −2,121−81.3% | Reduced | Holders |
| Q2 2022 | 2,608 | $110.2K | 0.1% | +1,886+261.2% | Added | Holders |
| Q1 2022 | 722 | $84.0K | 0.1% | −77,526−99.1% | Reduced | Holders |
| Q4 2021 | 78,248 | $604.0K | <0.1% | – | No prior filing | Holders |
| Q3 2021 | – | – | – | – | Not filed | Holders |
| Q2 2021 | 487 | $50.0K | <0.1% | – | No prior filing | Holders |